Malin Corporation | MLC - Acreedores Comerciales

Precio De Mercado
7.95
Cambio Diario
0 0%
Mensual
3.25%
Anual
-6.47%
Q2 Expectativa
7.71




Acreedores Comerciales Cambio Fecha
Akebia Therapeutics USD 21.18M 11.1M 2025-12
Alaunos Therapeutics USD 843K 34K 2025-09
ALKERMES USD 107.95M 39.95M 2025-12
Avita Medical AUD 8.96M 1.69M 2025-12
Dianthus Therapeutics USD 9.72M 3.02M 2025-12
Eurofins Scientific SE EUR 678M 72.7M 2025-12
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
IQVIA Holdings USD 3.75B 201M 2025-12
Lonza CHF 471M 3M 2024-12
Malin Corporation EUR 700K 200K 2024-12
Moderna USD 317M 50M 2025-12
Organon & Co USD 1.07B 7M 2025-09
Ovoca Bio EUR 186K 23K 2025-06
Revvity USD 185.46M 9.66M 2025-12
Tectonic Therapeutic USD 1.09M 392K 2025-12
Viatris USD 1.33B 6.4M 2025-09
Xeris Pharmaceuticals USD 3.08M 3.45M 2025-12